Brooks Laboratories Limited (NSE:BROOKS)
India · Delayed Price · Currency is INR 134.25
-0.91 (-0.67%)
Sep 30, 2025, 3:29 PM IST
Brooks Laboratories Market Cap
Brooks Laboratories has a market cap or net worth of 3.98 billion as of September 30, 2025. Its market cap has decreased by -3.48% in one year.
Market Cap
3.98B
Enterprise Value
4.04B
Revenue
901.36M
Ranking
n/a
PE Ratio
184.64
Stock Price
134.25
Market Cap Chart
Since September 5, 2011, Brooks Laboratories's market cap has increased from 105.21M to 3.98B, an increase of 3,684.22%. That is a compound annual growth rate of 29.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 3.95B | -16.36% |
| Dec 31, 2024 | 4.73B | 25.45% |
| Dec 29, 2023 | 3.77B | 39.59% |
| Dec 30, 2022 | 2.70B | 8.92% |
| Dec 31, 2021 | 2.48B | 51.02% |
| Dec 31, 2020 | 1.64B | 232.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,807.02B |
| Divi's Laboratories | 1,510.38B |
| Cipla | 1,211.15B |
| Apollo Hospitals Enterprise | 1,079.82B |
| Mankind Pharma | 1,024.84B |
| Zydus Lifesciences | 981.08B |
| Fortis Healthcare | 704.19B |
| Alkem Laboratories | 649.60B |